Caplight Directory>Investors>Negev Capital>Negevcap


Negev Capital

Negev Capital

Cayman Islandsnegevcap.com

Overview

Negev Capital is a venture capital firm that invests in early-stage companies developing novel drugs and medical interventions based on psychedelic compounds for neuropsychiatric disorders. The firm focuses on companies in the pre-clinical and Phase 1 stages of development, aiming to support the responsible, medical use of psychedelic medication. Their first fund, "Fund One", closed at over $30 million and is fully invested across 27 companies. The firm targets companies in the USA, Canada, Europe, and Israel.

Portfolio Companies

6

Investments

CompanyDateStageLead
Gilgamesh PharmaceuticalsDec 2022Series BCo-investor
Xylo BioOct 2022SeedCo-investor
Mindstate Design LabsFeb 2022SeedCo-investor
Mindstate GroupFeb 2022SeedCo-investor
Delix TherapeuticsSep 2021Series ACo-investor
View all investments

Key People

George Kikvadze

Limited Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCayman Islands
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.